Ondansetron: Clinical Trials

398 trials of Ondansetron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

274 completed, 45 unknown, 29 terminated, 16 recruiting. 100 Phase 4, 86 Not applicable, 86 Phase 2, 73 Phase 3, 55 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 4100Completed 65, Unknown 14, Not yet recruiting 6, Terminated 6, Recruiting 5, Active not recruiting 2, Withdrawn 2
Not applicable86Completed 57, Unknown 12, Withdrawn 7, Not yet recruiting 3, Terminated 3, Enrolling by invitation 2, Recruiting 2
Phase 286Completed 54, Terminated 11, Unknown 9, Recruiting 5, Not yet recruiting 4, Withdrawn 3
Phase 373Completed 46, Unknown 11, Terminated 6, Recruiting 4, Not yet recruiting 3, Withdrawn 2, Active not recruiting 1
Phase 155Completed 47, Terminated 5, Active not recruiting 1, Recruiting 1, Unknown 1
Early Phase 17Completed 6, Not yet recruiting 1

Follow Ondansetron: new trials by email Literature Review of Ondansetron trials Research Report on Ondansetron

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera
Ondansetron, Standard Cholera Care - Cholera (Disorder)
Phase 2Not yet recruitingPublic Interest Science Center1202026-10-202026-10-19
Dexamethasone Versus Ondansetron for Preventing Post-Spinal Hypotension in Preeclampsia
Dexamethasone, Ondansetron - Preeclampsia, Spinal Anesthesia-Induced Hypotension
Phase 4Not yet recruitingAssiut University1102026-10-012026-08-31
Ondansetron for the Prevention of Patient Self-Inflicted Lung Injury in Patients With ARDS - Pilot RCT
Ondansetron hydrochloride 8 mg IV Q8H, 0.9 % Normal Saline 10 ml - ARDS (Acute Respiratory Distress Syndrome), Invasive Mechanical Ventilation
Phase 2 / Phase 3Not yet recruitingCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal762026-10-012026-05-14
Effects of Ondansetron Timing During Spinal Anesthesia for Urologic Surgery
Ondansetron 8 mg, 0.9 % sodium chloride - Spinal Anesthesia-Induced Hypotension, Cerebral Oxygenation
Phase 4Not yet recruitingIstanbul University992026-09-302026-10-19
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
KarXT, Trimethobenzamide, Ondansetron - Healthy Volunteers
Phase 4RecruitingKaruna Therapeutics, Inc., a Bristol Myers Squibb company1802026-09-032026-10-15
Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy
ondansetron 4 mg, Dexamethasone (intravenous), Metoclopramide 10mg - Postoperative Nausea and Vomiting
Phase 4RecruitingFaisalabad Medical University2642026-09-012026-09-04
A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy
Netupitant/Palonosetron Hydrochloride, Ondansetron (Control), Aprepitant - Germ Cell Cancer
Early Phase 1Not yet recruitingOttawa Hospital Research Institute102026-08-012026-06-23
Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia
Ondansetron 4mg, metoclopramide - Intraoperative Nausea-retching-vomiting Episodes, Spinal Aneshtesia
Phase 4RecruitingSanliurfa Education and Research Hospital1202026-07-302026-10-01
Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer
5-HT3 receptor antagonist (e.g., ondansetron), Acupoint application - Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting
Not applicableRecruitingXiu Huang602026-07-152026-08-17
Aprepitant to Improve Same Day Discharge for TKA
Aprepitant Injection, Ondansetron (Zofran), Dexamethasone - PONV
Phase 4Not yet recruitingEndeavor Health3502026-07-012026-06-10
Ondansetron Versus Lidocaine for Preventing Pain on Propofol Injection.
Group C (Control), Ondansetron 8 mg, Lidocaine %2 ampoule - Anesthesia Induction, Propofol Pain Injection
Not applicableNot yet recruitingMongi Slim Hospital1562026-06-082026-06-08
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
ondansetron - Hepatocellular Carcinoma (HCC), IrAE
Phase 2RecruitingFirst Affiliated Hospital of Wenzhou Medical University1342026-04-302026-08-04
Prophylactic Ondansetron for Preventing Spinal Anesthesia-Induced Hypotension in Elective Cesarean Section
Ondansetron, Placebo (0.9% Sodium Chloride) - Hypotension, Spinal Anesthesia
Phase 4CompletedSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital962026-02-022026-10-21
Post Operative Shivering Following Anesthesia
Dexmedetomidin, Mg (magnesium sulfate), Ondansetron 8 mg - Shivering, Spinal Anesthesia
Not applicableNot yet recruitingSohag University602026-02-012026-02-04
Midazolam Adjunct Therapy for Prevention of PONV in Gynecological Laparoscopy
Midazolam 0.05 mg/kg IV as adjunct to dexamethasone and ondansetron for PONV prevention - Postoperative Nausea and Vomiting (PONV), Gynecological Laparoscopic Surgery
Phase 2CompletedHameed Latif Hospital, Lahore3002025-12-022026-06-25
Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy
Ondansetron Intraperitoneal Lavage, Saline Intraperitoneal Lavage - Postoperative Pain Management, Laparoscopic Cholecystectomy
Phase 4Active not recruitingInstituto Mexicano del Seguro Social402025-12-012025-12-16
Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting
nanocrystalline megestrol acetate combined with ondansetron, dexamethasone combined with ondansetron - Chemotherapy-Induced Nausea and Vomiting (CINV)
Phase 2Not yet recruitingAIPING ZHOU1272025-12-012025-11-24
Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients
Ondansetron (Zofran), chewing gum, Ondansetron + Chewing gum - Postoperative Nausea and Vomiting (PONV)
Phase 1Active not recruitingMakassed General Hospital902025-08-222025-10-01
Oral Ondansetron to Improve Patient Experience of Unsedated Esophagogastroduodenoscopy Pilot Study
ondansetron and dyclonine hydrochloride, dyclonine hydrochloride only - Esophagogastroduodensocopy (EGD) Procedure
Phase 4Active not recruitingPeking Union Medical College Hospital402025-07-012026-05-01
Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis
Ondansetron 8 mg ampoule, Metoclopramide 10 mg ampoule - Gastroenteritis
Phase 3UnknownGenuine Research Center, Egypt1262025-06-012024-09-26

Showing 20 of 398. Sign in to see all of them.

Conditions studied

Vomiting (116)  ·  Nausea (82)  ·  Postoperative Nausea and Vomiting (69)  ·  Pain, Postoperative (16)  ·  Alcoholism (14)  ·  Neoplasms (14)  ·  Hypotension (13)  ·  Gastroenteritis (9)  ·  Pain (9)  ·  Lymphoma, Non-Hodgkin (8)  ·  Leukemia, Myeloid, Acute (7)  ·  Agnosia (6)  ·  Breast Neoplasms (6)  ·  Multiple Myeloma (6)  ·  Schizophrenia (6)

Sponsors

Merck Sharp & Dohme LLC (17)  ·  GlaxoSmithKline (8)  ·  Assiut University (7)  ·  M.D. Anderson Cancer Center (6)  ·  Stanford University (6)  ·  Duke University (5)  ·  National Cancer Institute (NCI) (5)  ·  Tanta University (5)  ·  University of British Columbia (5)  ·  University of Virginia (5)  ·  Emory University (4)  ·  Mylan Pharmaceuticals Inc (4)  ·  Par Pharmaceutical, Inc. (4)  ·  University of Calgary (4)  ·  University of Colorado, Denver (4)

Countries

United States (162)  ·  Canada (37)  ·  Egypt (22)  ·  India (15)  ·  Pakistan (15)  ·  China (14)  ·  Turkey (Türkiye) (14)  ·  South Korea (12)  ·  Italy (10)  ·  United Kingdom (10)  ·  Czechia (8)  ·  Denmark (8)  ·  France (8)  ·  Poland (8)  ·  Thailand (8)

Top investigators

Bankole Johnson, DSc, MD, PhD (3)  ·  Christian Aumais (3)  ·  Eric Sicard, M.D. (3)  ·  Gary R. Morrow, PhD, MS (3)  ·  Robin Spiller (3)  ·  Simon Haroutounian, PhD (3)  ·  Stephen Freedman, MD (3)  ·  Bankole Johnson, DSc,MD,PhD (2)  ·  Dorian Williams, M.D. (2)  ·  Dr. I.S Gandhi (2)  ·  Dr. Tarang Shah, M.D. (2)

Results publications

PMID 21079721, PMID 25770814, PMID 10227938, PMID 10433490, PMID 10718794, PMID 11028830, PMID 11226762, PMID 11266262, PMID 11273930, PMID 11474424, PMID 11535479, PMID 11772809, PMID 11812709, PMID 11826129, PMID 12067003, PMID 12598264, PMID 12686700, PMID 12697943, PMID 12764341, PMID 12768180, PMID 12906958, PMID 1352024, PMID 14570668, PMID 14574212, PMID 14633551, PMID 15107371, PMID 15139073, PMID 15189396, PMID 1531705, PMID 1535245, PMID 16000093, PMID 1609990, PMID 16198982, PMID 16464423, PMID 16580905, PMID 16717343, PMID 16766588, PMID 16849762, PMID 16916674, PMID 17054284, PMID 17157685, PMID 17187507, PMID 17263269, PMID 17285386, PMID 17530482, PMID 17959952, PMID 18006188, PMID 18073548, PMID 18158814, PMID 18304050

NIH funding

2008 (3), 2009 (2), 2014 (2), R01AA010522 (2), 1RC2DA028905-01 (1), 2015 (1), P01DK068055 (1), P50AA010761 (1), R01AA012964 (1), R01AA013964 (1), R01AA018896 (1), R01DA021776 (1), R01DA029078 (1), R01DE005215 (1), R01GM123330 (1)